Skip to main content

DOSE · Rapid Dose Therapeutics Corp. · Financials

0.105 CAD +0.00 (+0.00%) At close · Nov 6 Intraday price with Plus
Market Cap
14.47M CAD
Shares
137.78M
Volume · Nov 6 8000 Avg daily vol (3M) 30.54K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
2.77M +33%
FY2026 Revenue FY2025–FY2026
Net Income
3.39M -37.3%
FY2026 Net Income FY2025–FY2026
Gross Margin
49.15% -7.4pp
FY2026 Gross Margin FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025
CAD 2.77M 2.09M
CAD 1.36M 1.18M
CAD 3.39M 5.4M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.